With Wilfred Mullens, Hospital Oost-Limburg (ZOL) and Hasselt University - Belgium & Alberto Esteban-Fernández, Hospital Universitario Severo Ochoa y Alfonso X El Sabio University - Spain.   This podcast addresses some of the main developments in congestion management in heart failure patients, especially those with cardiorenal syndrome. We discuss the ADVOR and CLOROTIC trials and their implications for clinical practice.

Cardiorenal axis and congestion

The HFA Cardio Talk provides the opportunity to anyone interested in Heart Failure to receive updates in the field with very specific and diverse topics, go on a deeper subject of an HFA course and to listen to a discussion of key opinion leaders with junior HF specialists. Each month, a new episode lasting approximately 15 minutes and taking the form of a conversation between a member of the HFA Young community and an internationally renowned expert is released.

You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and ESC TV Today. Check them out!

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Medicine

Science & Medicine

Health & Fitness

Self-Improvement

With Jozine M. ter Maaten, University Medical Centre Groningen, Groningen - Netherlands, Bart A. Mulder, 2022-2024, University Medical Centre Groningen, Groningen - Netherlands & Giuseppe Boriani, Polyclinic Modena University Hospital, Modena -Italy. Atrial fibrillation and heart failure often co-exist and influence each other. Treatment of AF specifically in the setting of heart failure can be challenging. Recently, new data emerged regarding the potential role of AF ablation in heart failure patients. In this podcast we discuss these in a special episode with a strong representation also from the EHRA Young highlighting the importance of interdisciplinary decision making in these patients.   Recommended readings from this episode: CASTLE HTx CASTLE AF CABANA results in heart failure patients This 2024 HFA CardioTalk podcast series is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor.

Atrial Fibrillation ablation in Heart Failure patients

With Cornelia Margineanu, Bucharest - Romania & Thomas Felix Luscher, London - UK A brief description of the discussion, which I have provided below: "In this episode, Dr. Cornelia Margineanu interviews Professor Thomas F. Lüscher on Education and professional development of the future generation of heart failure specialists, covering the entire pathway for young physicians, from training and having the right mentors to future trajectories. "This 2024 HFA CardioTalk podcast series is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor."

Future Pathways: Guiding the next generation of heart failure specialists

With Mateusz Sokolski, Wroclaw Medical University, Wroclaw - Poland & Amina Rakisheva, Scientific Research Institute of Cardiology and Internal Diseases, Almaty - Kazakhstan. Might heart failure be reversible or does it go only into remission in some cases? During this podcast, we discuss these issues, exploring the possibility of reversing heart failure and ending with regenerative medicine. "This 2024 HFA CardioTalk podcast series is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor."

Reversible causes of Heart Failure

With Alberto Esteban-Fernández. Severo Ochoa University Hospital, Madrid - Spain & John McMurray. BHF Glasgow Cardiovascular Research Centre, Glasgow - UK. We discuss the implementation of 2021 HF guidelines, the possibility of implementing foundational therapy in clinical practice, and difficulties and barriers. Also, we discuss future heart failure treatments in the coming years.  Access the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.  "This 2024 HFA CardioTalk podcast series is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor."

New perspectives in HF treatment

With Antonio Cannata, King’s College London - UK and Folkert Asselbergs, Amsterdam University Medical Centre - Netherlands. In this episode of HFA CardioTalk Antonio Cannata interviews one of the pioneer in digital medicine and artificial intelligence in cardiovascular medicine, Prof Folkert Asselbergs. Several interesting insights were discussed on the present role of AI in Heart Failure and what the future holds.  "This 2024 HFA CardioTalk podcast series is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor."

Cardiorenal axis and congestion

Download our free app to listen on your phone